Search
for
Sort by
Research 211–240 of 1000+
- Trichoscopy – a valuable tool for identifying conditions mimicking androgenetic alopecia
- Response of alopecia areata of the beard to oral tofacitinib
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- A clinical study on alopecia areata
- Effectiveness and safety of baricitinib in severe alopecia areata: 48-week results
- 52874 Timing of eyebrow and eyelash regrowth among subgroups of scalp responders during treatment of severe alopecia areata with baricitinib
- Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population
- Successful treatment of severe atopic dermatitis and alopecia universalis with upadacitinib in a 29-year-old male patient
- Limited Effectiveness of Platelet-Rich-Plasma Treatment on Chronic Severe Alopecia Areata
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis
- Severe Post-Bariatric Kwashiorkor Syndrome: A Case Report
- Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis
- Alopecia areata: A review
- Treatment of alopecia areata in pre‐adolescent children with oral tofacitinib: A retrospective study
- Dupilumab induces hair regrowth in pediatric alopecia areata: a real-world, single-center observational study
- Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world study
- Scalp hair regrowth is associated with improvements in health-related quality of life and psychological symptoms in patients with severe alopecia areata: results from two randomized controlled trials
- 41701 Efficacy of the Oral JAK1/JAK2 Inhibitor CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata: Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 Phase 3 Trial
- Clinical Outcomes for Uptitration of Baricitinib Therapy in Patients With Severe Alopecia Areata
- A consensus-based treatment algorithm for alopecia areata in adolescents and adults: integrating severity, quality of life, and disease dynamics
- BH31 Ritlecitinib for severe alopecia areata: does regional prescribing match national guidance?
- Case Report: Dupilumab induced sustained complete remission in a child with severe alopecia areata and markedly elevated IgE
- Efficacy, safety and dose response of STS01, a topical controlled release nanoparticle formulation (dithranol/Prosilic), in adults with mild to moderate patchy alopecia areata: A randomised, double-blind, multicentre, phase 2 trial
- Upadacitinib for the Treatment of Systemic Immune Co-Morbidity in One Case: Alopecia Areata, Vitiligo, Ankylosing Spondylitis, and Allergic Rhinitis-Asthma – Multifaceted Control
- Abrocitinib in the Treatment of Severe Alopecia Areata in a Pediatric Patient: A Case Report
- Ivarmacitinib stimulates hair regrowth in severe alopecia areata
- Tofacitinib treatment in a severe pediatric alopecia areata: A case report and a literature review
- A Real-World Study of Steroid-Free Monotherapy with Tofacitinib in Severe and Therapy-Recalcitrant Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Cases: A Retrospective Analysis
- Analyzing the role of tofacitinib in treatment of alopecia areata: A retrospective analysis from a tertiary care center of North India
- EE325 Budget Impact of Baricitinib for Patients with Severe Alopecia Areata